After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Scientists in Australia have discovered that a magnetic brain treatment already used for depression can boost the brain’s ...

The primary aim of the study is to evaluate Spectris' efficacy in slowing the progression of Alzheimer’s against sham for ...

Cognito Therapeutics Completes Enrollment in HOPE Pivotal Study of Spectris™ AD Therapy for the Treatment of Patients with Alzheimer’s Disease ...

A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Amyloid, a naturally occurring protein, can accumulate ...

Detailed price information for Cognition Therapeutics Inc (CGTX-Q) from The Globe and Mail including charting and trades.

Australian implant maker launched its new smart system through Hainan's special medical tourism pilot zone and Hong Kong in ...

Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back, but the companies aren't going to take the decision lying ...